Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.

Cancer causes & control : CCC - 1 Mar 2017

Bentmar Holgersson Magdalena, Ruhayel Yasir, Karlsson Magnus, Giwercman Aleksander, Bjartell Anders, Ohlsson Claes, Mellström Dan, Ljunggren Östen, Haghsheno Mohammad-Ali, Damber Jan-Erik, Lundberg Giwercman Yvonne

Abstract excerpt

BACKGROUND: In a previous population-based study on 3369 European men with self-reported prostate cancer (PCa), it was shown that androgen receptor (AR) haplotype designated H2 was associated with high levels of serum PSA (prostate-specific antigen) concentration, and, at the same time, with low risk for PCa. The aim of this study was to replicate this finding in other cohorts, with registry-based cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Receptors, Androgen

Share to Risk Factors

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 28176139
DOI: 10.1007/s10552-017-0859-1
PMCID: PMC5325831

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele.PMID 28176139Read ↗

A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSemantic proximity Read ↗

Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.Semantic proximity Read ↗

A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.Semantic proximity Read ↗

Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness.Semantic proximity Read ↗

Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.Semantic proximity Read ↗

Androgens and the molecular epidemiology of prostate cancer.Semantic proximity Read ↗

Inherited variation in hormone-regulating genes and prostate cancer survival.Semantic proximity Read ↗

Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer riskSemantic proximity Read ↗

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).Semantic proximity Read ↗

Association of variants in estrogen-related pathway genes with prostate cancer risk.Semantic proximity Read ↗

Pharmacogenetics of human androgens and prostatic diseases.Semantic proximity Read ↗

Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.